Work

Supplementary Table 5 from Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Table 5: Differential gene expression analysis between B16 PAK4 KO anti-PD-1 vs WT anti-PD-1 tumors in vivo at day 10. Showing genes with q < 0.05 and log2FC > 1 or < -1.

DOI: 10.1158/2767-9764.22545378

Authors: Gabriel Abril-Rodriguez, Davis Y. Torrejon, Daniel Karin, Katie M. Campbell, Egmidio Medina, Justin D. Saco, Mildred Galvez, Ameya S. Champhekar, Ivan Perez-Garcilazo, Ignacio Baselga-Carretero, Jas Singh, Begoña Comin-Anduix, Cristina Puig-Saus, Antoni Ribas

Institutions: University of California, Los Angeles, Arcus Biosciences (United States), UCLA Jonsson Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Funders: Melanoma Research Alliance, American Society of Clinical Oncology, Parker Institute for Cancer Immunotherapy, National Institutes of Health, Center for AIDS Research, University of Washington, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, UCLA AIDS Institute

Awards: G1100959374, G1685810784, UCLA-Caltech Medical Scientist Training Program, G6112660351, G7710859931, UCLA Center for AIDS Research (CFAR), G8211987807, G8499101873, G9000014846, G9000096164, G9000114644, G9000115021, G9000255545, G9000261587, G9000351677, UCLA Tumor Immunology Institutional Training Grant, Cancer Center Support Grant

OpenAlex ID: W4362620644

Cites: 34

Cited by:

Related to: 10